The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLIX.u

Vasculitis, pulmonary (w/wo AH), extrapulmonary, systemic: ANCA-positive

Publications

Eindhoven S, Levels J, Huisman M, de Winter KR, Dalm V, Alwani R

MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2017;13;49 — 2017 — 49

Duggal T, Segal P, Shah M, Carter-Monroe N, Manoharan P, Geetha D

Antineutrophil cytoplasmic antibody vasculitis associated with influenza vaccination.

American journal of nephrology 2013;38;174-8 — 2013 — 174-8

Birck R, Kaelsch I, Schnuelle P, Flores-Suárez LF, Nowack R

ANCA-associated vasculitis following influenza vaccination: causal association or mere coincidence?

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2009 Sep;15;289-91 — 2009 Sep — 289-91